Interventional device developer Boston Scientific has signed an agreement to sell its investments in a portfolio of companies in order to focus on its core businesses and increase shareholder value, the Natick, MA-based company said.
Boston Scientific plans to sell the investments to Saints Capital of San Francisco, a secondary direct-investment firm; the transaction will raise pretax proceeds of more than $100 million.
The company also plans to sell investments in a portfolio of venture funds and companies to Paul Capital Partners, also of San Francisco, for pretax proceeds of $40 million.
Related Reading
Boston Scientific wins FDA clearance for heart failure lead, May 19, 2008
Boston Scientific launches Latitude analysis program, May 16, 2008
Canadian court dismisses J&J lawsuit against Boston Scientific, May 9, 2008
Boston Scientific completes enrollment in MADIT-CRT trial, April 24, 2008
Boston Scientific earns Canadian approval for Taxus, April 17, 2008
Copyright © 2008 AuntMinnie.com
